Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BI-69A11 ((E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one) is a dual AKT and NFkB pathway inhibitor. It enhances the susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
2 mg | In stock | $ 52.00 | |
5 mg | In stock | $ 75.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 189.00 | |
50 mg | In stock | $ 272.00 | |
100 mg | In stock | $ 389.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 94.00 |
Description | BI-69A11 ((E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one) is a dual AKT and NFkB pathway inhibitor. It enhances the susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt. |
Synonyms | BI 69A11, (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one |
Molecular Weight | 425.87 |
Formula | C25H16ClN3O2 |
CAS No. | 1233322-09-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (129.15 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BI-69A11 1233322-09-2 Cytoskeletal Signaling NF-Κb PI3K/Akt/mTOR signaling NF-κB Akt BI 69A11 BI69A11 BI-69A-11 (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one inhibitor inhibit